T1	Participants 71 123	patients with human immunodeficiency virus infection
T2	Participants 220 262	human immunodeficiency virus type 1 (HIV-1
T3	Participants 571 660	12 HIV-infected patients (mean [+/- standard deviation] CD4+ cell count, 304 +/- 213/mm3)
